Home > National Drug Code (NDC) > Rendrevie Sun Screen SPF35 PA

Rendrevie Sun Screen SPF35 PA - 76173-1001-2 - (OCTINOXATE, TITANIUM DIOXIDE, OCTISALATE)

Alphabetical Index


Drug Information of Rendrevie Sun Screen SPF35 PA

Product NDC: 76173-1001
Proprietary Name: Rendrevie Sun Screen SPF35 PA
Non Proprietary Name: OCTINOXATE, TITANIUM DIOXIDE, OCTISALATE
Active Ingredient(s): 5.625; 2.25; 3.89    mL/75mL; mL/75mL; mL/75mL & nbsp;   OCTINOXATE, TITANIUM DIOXIDE, OCTISALATE
Administration Route(s): TOPICAL
Dosage Form(s): CREAM
Coding System: National Drug Codes(NDC)

Labeler Information of Rendrevie Sun Screen SPF35 PA

Product NDC: 76173-1001
Labeler Name: Cellinbio Co Ltd
Product Type: HUMAN OTC DRUG
FDA Application Number: part352
Marketing Category: OTC MONOGRAPH NOT FINAL
Start Marketing Date: 20110720

Package Information of Rendrevie Sun Screen SPF35 PA

Package NDC: 76173-1001-2
Package Description: 1 TUBE in 1 BOX (76173-1001-2) > 75 mL in 1 TUBE (76173-1001-1)

NDC Information of Rendrevie Sun Screen SPF35 PA

NDC Code 76173-1001-2
Proprietary Name Rendrevie Sun Screen SPF35 PA
Package Description 1 TUBE in 1 BOX (76173-1001-2) > 75 mL in 1 TUBE (76173-1001-1)
Product NDC 76173-1001
Product Type Name HUMAN OTC DRUG
Non Proprietary Name OCTINOXATE, TITANIUM DIOXIDE, OCTISALATE
Dosage Form Name CREAM
Route Name TOPICAL
Start Marketing Date 20110720
Marketing Category Name OTC MONOGRAPH NOT FINAL
Labeler Name Cellinbio Co Ltd
Substance Name OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE
Strength Number 5.625; 2.25; 3.89
Strength Unit mL/75mL; mL/75mL; mL/75mL
Pharmaceutical Classes

Complete Information of Rendrevie Sun Screen SPF35 PA


General Information